Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Hypnotherapy significantly improves symptoms in IBS patients

Hypnotherapy significantly improves quality of life in irritable bowel syndrome patients, both in the short- and long-term, claim British researchers reporting to the BSG conference.

News image

fiogf49gjkf04

Two research teams investigated the impact of hypnotherapy on quality of life in patients suffering from irritable bowel syndrome (IBS).

They presented their findings at the British Society of Gastroenterology Annual Meeting in Birmingham, England.

In the first study, investigators from the Western General Hospital in Edinburgh, Scotland, evaluated the impact of gut-directed hypnotherapy upon health-related quality of life (HRQoL) status in IBS patients.

A total of 75 IBS patients (55 females, median age 37 years) were enrolled in the trial.

The predominant symptoms among the patients were abdominal pain in 46 (61%), altered bowel habit in 24 (32%), and abdominal bloating in 5 (7%).

Hospital Anxiety and Depression Scales, and an IBS disease-specific quality of life tool (IBSQoL) were used to measure outcomes.

The researchers took measurements at baseline (pre-treatment) and at 3 months post-treatment.

There were found to be statistical improvements in all domains of the IBSQoL (emotional, mental, and physical health, sleep, energy, diet, and social and physical role) after treatment.

Improvements were most marked in female patients, particularly those with predominant abdominal pain.

Furthermore, significant improvements were seen in both males and females for anxiety and depression.

Dr G. D. Smith commented that gut-directed hypnotherapy had a very positive impact upon psychological well being and HRQoL in IBS.

This appeared most effective in patients with a predominant symptom of abdominal pain and bloating.

The authors recommended that a randomized, controlled study of hypnotherapy in IBS should be conducted.

Hypnotherapy improved symptoms and quality of life in IBS patients.
BSG
In the second study, a team from the University Hospital of South Manchester, England, conducted a long-term follow-up of IBS patients treated with hypnotherapy.

A total of 239 IBS patients, who had undergone hypnotherapy between 1 and 5 years previously, were contacted and asked to complete 3 separate questionnaires. Of these, 178 patients responded.

In a Subjective Assessment Questionnaire (assessing effects of hypnotherapy, medication use, and consultation rates) 86% of patients were found to have improved at the end of hypnotherapy (62% of whom rated symptoms as very much better).

Of the patients that improved, 83% reported that, since finishing hypnotherapy, symptoms had remained the same as at the end of hypnotherapy, or had continued to improve. However, 17% had some deterioration.

In addition, 59% of patients did not require any medication. Of those who did, 40% took it less often than previously.

Three quarters of the patients consulted their GP and/or hospital consultant less often about IBS symptoms, and 49% less about other symptoms.

All IBS measures in an IBS Questionnaire (rating severity of symptoms and QOL) remained significantly better at follow-up than before hypnotherapy. These included pain severity and frequency, bloating, bowel habit dissatisfaction, and life interference.

There was only slight deterioration in some of the measures at follow-up, compared with post-hypnotherapy.

Extra-colonic symptoms, QOL, and Hospital Anxiety and Depression scores all remained improved at follow-up.

Author W. M. Gonsalkorale said on behalf of the group, "This study confirms the long-term benefit of hypnotherapy."

"In addition, the substantial reduction of medication and consultation rates highlights the significant economic advantages of this form of treatment," it was concluded.

BSG
19 March 2002

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us